|  Find a Doctor  | Events   Getting to NCIS  | Appointment  | Contact Us  | Newsroom  |  Make a Gift  | About NUHS 

 







Home > Patient and Visitors > Clinical Services > Division of Oncology Pharmacy

Division of Oncology Pharmacy

The Cancer Centre Pharmacy serves all outpatients at the cancer centre infusion centres as well as patients who have been warded in the hospital. They include both adult and paediatric haematology-oncology patients, blood and marrow transplant patients, benign haematology patients, uro-oncology patients, gynae-oncology patients and also patients from rheumatology, renal services who require immunosuppressant therapy.

 

It provides specialized oncology drug compounding services for all anti-cancer therapies in NCIS as well as the filling and dispensing of oral anti-cancer drugs and related supportive therapy at the outpatient cancer centre pharmacy. Besides specialised drug compounding and distribution services, oncology pharmacists are involved in the provision of specialised clinical pharmacy services such as patient counseling of new anti-cancer therapies and the provision of drug information to patients and members of our healthcare team.

 

The Division of Oncology Pharmacy is very much involved in the conduct and management of clinical trials, both investigator-initiated and pharmaceutical industry-initiated.  The oncology pharmacists also conduct clinical oncology pharmacy based research here.

 

It runs the safe handling of anti-cancer drugs and aseptic dispensing certificate course as well as aseptic dispensing validation tests for both pharmacists and pharmacy technicians from NUH and external organisations. The Cancer Centre Pharmacy frequently hosts local and foreign pharmacy undergraduates, pre-registration pharmacists, pharmacists, pharmacy technicians, nurses and healthcare administrators to share about its specialized oncology services 

 

The Cancer Centre Pharmacy is part of the Department of Pharmacy, Clinical Support Services, NUH and works closely with the National University Cancer Institute, Singapore (NCIS).